Cargando…

Hyaluronan stimulates pancreatic cancer cell motility

Hyaluronan (HA) accumulates in pancreatic ductal adenocarcinoma (PDAC), but functional significance of HA in the aggressive phenotype remains unknown. We used different models to investigate the effect of HA on PDAC cell motility by wound healing and transwell migration assay. Changes in cell motili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Xiao-Bo, Kohi, Shiro, Koga, Atsuhiro, Hirata, Keiji, Sato, Norihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826246/ https://www.ncbi.nlm.nih.gov/pubmed/26684359 http://dx.doi.org/10.18632/oncotarget.6617

Ejemplares similares

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016)

4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions
por: Cheng, Xiao-Bo, et al.
Publicado: (2018)

Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2015)

KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer
por: Kohi, Shiro, et al.
Publicado: (2017)

Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma
por: Kudo, Yuzan, et al.
Publicado: (2019)

Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight
por: Sato, Norihiro, et al.
Publicado: (2016)

Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation
por: Kohi, Shiro, et al.
Publicado: (2016)

Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2013)

Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer
por: Oba, Takuya, et al.
Publicado: (2021)

Prognostic and functional role of hyaluronan-binding protein 1 in pancreatic ductal adenocarcinoma
por: Adachi, Yasuhiro, et al.
Publicado: (2022)

Negative regulation between the expression levels of receptor for hyaluronic acid-mediated motility and hyaluronan leads to cell migration in pancreatic cancer
por: Cheng, Xiao-Bo, et al.
Publicado: (2020)

An advanced bipolar device helps reduce the rate of postoperative pancreatic fistula in laparoscopic gastrectomy for gastric cancer patients: a propensity score-matched analysis
por: Shibao, Kazunori, et al.
Publicado: (2022)

Triple bypass for advanced pancreatic head cancer associated with biliary stricture, duodenal stenosis, and recurrent obstructive pancreatitis
por: Kudo, Yuzan, et al.
Publicado: (2016)

The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer
por: Mele, Valentina, et al.
Publicado: (2017)

Changes in operative trends and short‐term outcomes of surgery for congenital biliary dilatation in adults using real‐world data: A multilevel analysis based on a nationwide administrative database in Japan
por: Mori, Yasuhisa, et al.
Publicado: (2022)

Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer
por: Tang, Yan-ping, et al.
Publicado: (2021)

The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder
por: Niedworok, Christian, et al.
Publicado: (2013)

TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan
Publicado: (1993)

Correction. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
Publicado: (1992)

Accumulation of Extracellular Hyaluronan by Hyaluronan Synthase 3 Promotes Tumor Growth and Modulates the Pancreatic Cancer Microenvironment
por: Kultti, Anne, et al.
Publicado: (2014)

Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor
por: He, Zhengcheng, et al.
Publicado: (2020)

Effect of receptor for hyaluronan-mediated motility inhibition on radiosensitivity of lung adenocarcinoma A549 cells
por: Gao, Chunzi, et al.
Publicado: (2019)

Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer
por: Yoshida, Eri, et al.
Publicado: (2016)

Cytokines and Growth Factors Stimulate Hyaluronan Production: Role of Hyaluronan in Epithelial to Mesenchymal-Like Transition in Non-Small Cell Lung Cancer
por: Chow, Geraldine, et al.
Publicado: (2010)

Hyaluronan and Hyaluronan Binding Proteins Are Normal Components of Mouse Pancreatic Islets and Are Differentially Expressed by Islet Endocrine Cell Types
por: Hull, Rebecca L., et al.
Publicado: (2012)

Hyaluronan in the Cancer Cells Microenvironment
por: Karousou, Evgenia, et al.
Publicado: (2023)

Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
por: Hinneh, Josephine A., et al.
Publicado: (2023)

The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44
por: Zhao, Chunmei, et al.
Publicado: (2019)

Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia
por: Hirakawa, Toshiki, et al.
Publicado: (2016)

Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells
por: Niizeki, H, et al.
Publicado: (2002)

COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor
por: Li, Junyang, et al.
Publicado: (2017)

Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer
por: Koltai, Tomas, et al.
Publicado: (2021)

The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury
por: Cui, Zheng, et al.
Publicado: (2018)

Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer
por: Montagner, Isabella Monia, et al.
Publicado: (2015)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Developing Fluorescent Hyaluronan Analogs for Hyaluronan Studies
por: Wang, Wei, et al.
Publicado: (2012)

PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells
por: Smith, Alena J., et al.
Publicado: (2016)

Endotoxin free hyaluronan and hyaluronan fragments do not stimulate TNF-α, interleukin-12 or upregulate co-stimulatory molecules in dendritic cells or macrophages
por: Dong, Yifei, et al.
Publicado: (2016)

The Potency of Hyaluronan of Different Molecular Weights in the Stimulation of Blood Phagocytes
por: Safrankova, Barbora, et al.
Publicado: (2010)

Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer
por: Nunomiya, Keiko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j8d61doe9dg9b17h50vqi0546i